Sequoia Pharmaceuticals, Inc.
Sequoia Pharmaceuticals is a private, venture-capital funded company founded in 2002. We are engaged in the discovery and development of novel antiviral therapeutics with a focus on combating drug-resistant HIV and HCV. We are also developing pharmacokinetic enhancers to improve the exposure of co-administered therapeutics.
Learn More about Sequoia Pharmaceuticals
Employment Opportunites at Sequoia
October 26, 2008
Sequoia Pharmaceuticals presents in vitro and first-in-human data supporting further development of SPI-256, a novel investigational protease inhibitor
Read More
December 6, 2007
Sequoia files an IND for a pharmacokinetic enhancer: the second IND for 2007.
Read More
October 29, 2007
Steve Skolsky joins as President and CEO
Read More
June 2007
Sequoia has initiated Phase 1 Clinical Trials on a novel HIV protease inhibitor.